Who Owns AARD?

Aardvark Therapeutics, Inc. Common Stock — Institutional Ownership & 13F Holdings

$5.23

+0.02 (+0.38%)

Market Cap

$120.4M

Shares Outstanding

21,816,041

Institutional Holders

27

Total Inst. Value

$55.8M

% of Float Held

77.7%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Decheng Capital LLC$29.4M3,917,299
2Laurion Capital Management LP$6.1M808,243
3Cormorant Asset Management, LP$6.0M800,189
4BRAIDWELL LP$3.8M500,000
5SUVRETTA CAPITAL MANAGEMENT, LLC$2.3M312,500
6ADAGE CAPITAL PARTNERS GP, L.L.C.$1.9M250,000
7VANGUARD GROUP INC$1.2M165,491
8Schonfeld Strategic Advisors LLC$1.1M143,951
9SILVERARC CAPITAL MANAGEMENT, LLC$897K119,496
10CANTOR FITZGERALD, L. P.$501K66,682

Related Stocks

Frequently Asked Questions

How many institutional investors hold AARD?

As of Q1 2025, 27 institutional investors report holding AARD (Aardvark Therapeutics, Inc. Common Stock) in their 13F filings.

What percentage of Aardvark Therapeutics, Inc. Common Stock is owned by institutions?

Institutional investors hold approximately 77.7% of Aardvark Therapeutics, Inc. Common Stock's float as reported in SEC 13F filings.

Which hedge fund owns the most AARD?

The largest institutional holder of AARD is Decheng Capital LLC with $29.4M in shares.

Are institutions buying or selling AARD?

This quarter, 27 institutions opened new positions in AARD and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.